about
Environmental scanning electron microscope imaging of vesicle systems.Design of Experiments to Study the Impact of Process Parameters on Droplet Size and Development of Non-Invasive Imaging Techniques in Tablet CoatingA Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol.An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.Preparation and characterization of amino acids-based trimethoprim salts.Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.The application of monolayer studies in the understanding of liposomal formulations.Trigger release liposome systems: local and remote controlled delivery?The impact of ageing on the barriers to drug delivery.Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.Challenges and emerging solutions in the development of compressed orally disintegrating tablets.Systems biology approach to study permeability of paracetamol and its solid dispersion.Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination.Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.Effects of ball-milling on PLGA polymer and its implication on lansoprazole-loaded nanoparticles.Characterisation and surface-profiling techniques for composite particles produced by dry powder coating in pharmaceutical drug delivery.A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug.A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.Corrigendum: Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers.The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets.Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy.Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents.Preparation, optimisation and characterisation of lyophilised rapid disintegrating tablets based on gelatin and saccharide.Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.High-strength resorbable brushite bone cement with controlled drug-releasing capabilities.Understanding the compaction behaviour of low-substituted HPC: macro, micro, and nano-metric evaluations.Environmental Scanning Electron Microscope Imaging of Vesicle Systems.Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets.A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets.Amino acids as cryoprotectants for liposomal delivery systemsQuality by Design (QbD) based process optimisation to develop functionalised particles with modified release properties using novel dry particle coating techniquePhysicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomesLyophilisation and sterilisation of liposomal vaccines to produce stable and sterile productsGenomic evaluation during permeability of indomethacin and its solid dispersionUse of amino acids as counterions improves the solubility of the BCS II model drug, indomethacin
P50
Q33518715-B0138B2F-92BA-43E8-9842-A87FE59ABBBCQ36109032-CCF4A5F2-5650-4EAE-8885-2AA917C5974EQ36266012-10A35E30-DC07-4A62-8338-B8F682120071Q36400459-0B923814-8D72-448E-B3AD-FAACF4A6B559Q37327809-612A5E3A-3F99-4D38-8089-4479BE1475F3Q37712256-29E37EFD-3E24-4E5F-8520-8231ECCC6FAAQ37830905-4A0AEB78-CF37-4756-B723-90F37D896040Q37972351-3F1904CF-03FA-4BAD-B827-067B4B1695A2Q37979949-7108263A-11F6-4A75-844B-1558629627C1Q38084740-CC17A91A-F1CB-4F24-B13A-E41215F408C6Q38232117-74015E7D-A2C9-4ECC-8E49-7888C3D1779FQ38338456-BA1F4146-1F37-4478-AA61-C4259268687DQ38544037-4BDE4438-8964-45E0-B6E8-84449C4A6A07Q38569768-56E0E1A8-88DB-4D00-A112-AD02C179BE29Q38653908-927CC064-B346-4C30-9798-AD6830BF6535Q38675006-311D9029-6099-48E0-BAFE-8B3EEEA5CC1DQ39179137-F0D7A584-A6B0-49BB-AA14-0981083806D6Q40645278-4525DA27-C571-4950-BC1D-5624F314EAC0Q41462462-76E9F0BA-DA0A-4D1C-A602-BA665927C47BQ41767196-9407D5D2-97CB-43C5-A8E1-C125FD535E3BQ41978062-E795CF36-4C4D-41EC-9667-8DA4C17E6507Q42840446-78A6579E-007E-413E-A84A-9EDA9FB9D50EQ43120809-90D79AB8-8B90-4BB4-858C-96B605007E27Q43253436-D71030AE-308B-46D3-9F99-5B66042D8E55Q45110091-6C49E00D-3D72-4784-8A2C-0431BF7A7852Q45776580-A3938DE8-35C1-4EBA-A5BF-D8BA03CDDF6EQ46361536-ED2F5659-15B4-4E13-9A22-C2E30CE46C31Q47835131-E4390FCE-C74A-4B86-B856-77F1DC927D78Q51067742-DAED6A91-43D2-44EE-B700-874B77F335AEQ51147872-AFAD8416-97C7-4B9D-9635-CF8A17840678Q51746471-83DE5109-0389-405A-9537-84AB89195089Q53512345-1A457ABD-930A-4794-815F-AA3475972411Q53722027-BE5215C7-7EB0-4B65-AE5E-9FEB3A38BABDQ57102334-6E43F8F0-8C2F-4ADA-80CE-FB5FC6A160EEQ58085018-76576F89-F441-463F-A9E9-1F4C58AB85DEQ61037684-9B4F1019-1EF1-4C9A-BCC0-3A17DF8BD9A8Q80205582-E2BB6B86-DBC3-463B-ACEB-CDE123997951Q80335106-84A05736-8053-4B30-85DC-F2E0592FBCF3Q82470109-BF6BF162-7A25-43A0-B753-616665288915Q83755611-1044E695-2BC6-48E2-9FB1-2B88733401CD
P50
description
investigador
@es
researcher
@en
name
Afzal R Mohammed
@en
Afzal R Mohammed
@nl
type
label
Afzal R Mohammed
@en
Afzal R Mohammed
@nl
prefLabel
Afzal R Mohammed
@en
Afzal R Mohammed
@nl
P31
P496
0000-0002-5212-3040